dr. sweeney on the optimal use of cabazitaxel
Published 9 years ago • 585 plays • Length 2:32Download video MP4
Download video MP3
Similar videos
-
1:20
dr. sweeney on evolving role of chemotherapy for hormone-sensitive prostate cancer
-
1:33
dr. oh discusses the utility of cabazitaxel
-
1:09
dr. sweeney on chemotherapy in prostate cancer
-
1:55
dr. sweeney on chemotherapy versus abiraterone for mcrpc
-
1:22
cabazitaxel improves rpfs in patients with mcrpc
-
7:09
cabazitaxel use in metastatic prostate cancer
-
1:30
cabazitaxel impacts sequencing strategies in prostate cancer
-
1:32:53
dr. jeff sankoff (the tridoc) - health and medicine in endurance sports | ep#442
-
0:34
discussing the safety profile of cabazitaxel in mcrpc
-
3:13
treatment options in metastatic prostate cancer
-
1:45
dr. sweeney discusses tailoring treatment in prostate cancer
-
1:04
dr. grivas on potential combinations with cabazitaxel in prostate cancer
-
4:50
card trial: cabazitaxel after ar-targeted therapy in mcspc
-
2:46
dr. sweeney on the phase iii enzamet trial in metastatic hormone-sensitive prostate cancer
-
6:16
evolution of treatment for metastatic castration-resistant prostate cancer
-
1:31
dr. moul discusses immunotherapy in prostate cancer
-
3:16
counseling patients with mcrpc
-
3:55
ipatential150 shows promise of ipatasertib addition in some mcrpc patients | christopher sweeney
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide